Chen Liu1, Qingfeng Fu2, Guoju You3

  • 1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.

STAR protocols
|December 21, 2024
PubMed
概括

本研究概述了一项协议,以评估人类胚胎中的先天性淋巴细胞 (ILC) 潜力. 它使研究人员能够从早期胚胎阶段研究这些关键免疫细胞的发育和功能.

相关概念视频